Genetic approaches to CNS disorders with particular reference to GABAA-receptor mutations.
The tools of molecular biology will bring the field of human genetics into a new era by permitting the analysis of the genetic contribution to disease. Most single gene disorders, inherited in a Mendelian fashion, will be molecularly diagnosed. In addition, the genetic susceptibility of common, complex diseases such a schizophrenia can be clarified, even though the conditions are not inherited as Mendelian characteristics. The mapping of the human genome will increase the rate at which new disease genes are identified and isolated. Finally, the development of genetically engineered animal models will help to dissect the steps involved in physiological and pathophysiological processes and thereby enhance our understanding of complex biological systems.
Mohler
H
H
Institute of Pharmacology, ETH, Switzerland.
D000437:Alcoholism / Q000235:genetics; D017204:Angelman Syndrome / Q000235:genetics; D000818:Animals; D002493:Central Nervous System Diseases / Q000235:genetics*; D002972:Cleft Palate / Q000235:genetics; D005821:Genetic Techniques; D006801:Humans; D007305:Insecticide Resistance / Q000235:genetics; D016296:Mutagenesis; D010375:Pedigree; D011487:Protein Conformation; D011963:Receptors, GABA-A / Q000235:genetics*
D011963:Receptors, GABA-A